The Patent Finder

Atlas Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Atlas Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Atlas Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,333,309Human-derived glycoprotein, biologically active factor which includes glycoprotein, and pharmaceutical product which comprises biologically active factor as active component
Lapsed on the fee record
Ended Dec 25, 2013 · USPTO record
Lapsed on the fee recordEnded Dec 25, 2013USPTO record
US 6,306,827Method for preventing and/or treating renal disease
Lapsed on the fee record
Ended Oct 23, 2013 · USPTO record
Lapsed on the fee recordEnded Oct 23, 2013USPTO record
US 7,306,791Agent for preventing and/or treating multiple organ failure
Lapsed on the fee record
Ended Dec 11, 2011 · USPTO record
Lapsed on the fee recordEnded Dec 11, 2011USPTO record
US 7,138,372Agent for preventing and/or treating cachexia
Lapsed on the fee record
Ended Nov 21, 2010 · USPTO record
Lapsed on the fee recordEnded Nov 21, 2010USPTO record
US 7,115,568Methods using TCF II
Lapsed on the fee record
Ended Oct 3, 2010 · USPTO record
Lapsed on the fee recordEnded Oct 3, 2010USPTO record
US 6,399,744TCF mutant
Lapsed on the fee record
Ended Jun 4, 2010 · USPTO record
Lapsed on the fee recordEnded Jun 4, 2010USPTO record
US 5,328,836Plasmids containing DNA encoding the amino acid sequence of TCF-II and use thereof
Term ended
Term ended no later than Jul 12, 2014 · Low confidence
Term endedTerm ended no later than Jul 12, 2014Low confidence
US 5,510,327Highly concentrated TCF pharmaceutical preparations
Term ended
Term ended no later than Apr 23, 2016 · Low confidence
Term endedTerm ended no later than Apr 23, 2016Low confidence
US 5,587,359Human derived glycoprotein, biologically active factor which includes glycoprotein and pharmaceutical product
Term ended
Term ended no later than Dec 24, 2016 · Low confidence
Term endedTerm ended no later than Dec 24, 2016Low confidence
US 5,658,742Monoclonal antibody
Term ended
Term ended no later than Aug 19, 2017 · Low confidence
Term endedTerm ended no later than Aug 19, 2017Low confidence
10 of 12 patents shown.
Pro members see all 12.
Pro members: see all 12 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited